Patient Monitoring Global Market – Forecast To 2020
1 EXECUTIVE SUMMARY 23
2 INTRODUCTION 26
- 2.1 KEY TAKE AWAYS 26
- 2.2 REPORT DESCRIPTION 26
- 2.3 MARKETS COVERED 28
- 2.4 STAKEHOLDERS 31
- 2.5 RESEARCH METHODOLOGY 31
- 2.5.1 MARKET SIZE ESTIMATION 32
- 2.5.2 MARKET CRACK DOWN & DATA TRIANGULATION 35
- 2.5.3 SECONDARY RESEARCH RESOURCES 36
- 2.5.4 PRIMARY RESEARCH RESOURCES 37
- 2.5.5 ASSUMPTIONS 37
3 MARKET ANALYSIS 38
- 3.1 INTRODUCTION 38
- 3.2 MARKET SEGMENTATION 39
- 3.3 FACTORS INFLUENCING MARKET 40
- 3.3.1 DRIVERS AND OPPORTUNITIES 41
- 3.3.1.1 Increasing geriatric population and rising incidences of lifestyle
diseases 41
- 3.3.1.2 Rise in sales of remote monitoring systems favoring reduced healthcare expenditure 41
- 3.3.1.3 Advancement of new technologies and less staff usage 42
- 3.3.1.4 Expansion of point-of-care devices 42
- 3.3.1.5 Emerging markets and low cost manufacturers 42
- 3.3.1.6 Advancement in wireless and sensor technologies 43
- 3.3.1 DRIVERS AND OPPORTUNITIES 41
- 3.3.2 RESTRAINTS AND THREATS 43
- 3.3.2.1 Financial crisis 43
- 3.3.2.2 High pricing of devices 44
- 3.3.2.3 Reimbursement issues 44
- 3.3.2.4 Uncertain return of investment (ROI) 45
- 3.3.3 BURNING ISSUES 45
- 3.3.3.1 Thermal injuries caused by devices 45
- 3.3.4 WINNING IMPERATIVE 46
- 3.3.4.1 Wireless technology adoption at lower cost 46
- 3.4.1 THREAT OF NEW ENTRANTS 47
- 3.4.2 THREAT OF SUBSTITUTES 48
- 3.4.3 RIVARLY AMONG EXISTING COMPETITORS 48
- 3.4.4 BARGAINING POWER OF SUPPLIERS 48
- 3.4.5 BARGAINING POWER OF BUYERS 48
- 3.5.1 U.S. 49
- 3.5.2 EUROPE 50
- 3.5.3 CHINA 50
- 3.5.4 INDIA 51
- 3.5.5 JAPAN 51
- 3.8.1 SOME OF THE RECENT WEARABLE DEVICES ARE: 66
- 3.9.1 SOME OF THE DEVICES USED BY OLDER ADULTS 72
4 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY DEVICE 73
- 4.1 INTRODUCTION 73
- 4.2 CARDIAC MONITORS 76
- 4.2.1 ELECTROCARDIOGRAM 79
- 4.2.2 EVENT MONITOR 81
- 4.2.3 CARDIAC OUTPUT MONITOR 82
- 4.2.4 HOLTER MONITOR 84
- 4.2.5 IMPLANTABLE LOOP RECORDER 85
- 4.3 HEMODYNAMIC MONITORS 87
- 4.3.1 BLOOD PRESSURE MONITORS 89
- 4.3.2 BLOOD GLUCOSE MONITORS 92
- 4.3.2.1 Single point blood glucose monitors 93
- 4.3.2.2 Continuous glucose monitoring devices 93
- 4.3.3 BLOOD GAS AND ELECTROLYTE ANALYZERS 95
- 4.4 MULTI-PARAMETER MONITORS 96
- 4.4.1 LOW ACUITY 98
- 4.4.2 MID ACUITY 100
- 4.4.3 HIGH ACUITY 101
- 4.5 NEUROLOGICAL MONITORS 102
- 4.5.1 ELECTROENCEPHALOGRAM 105
- 4.5.2 TRANSCRANIAL DOPPLER 107
- 4.5.3 MAGNETOENCEPHALOGRAPH 109
- 4.5.4 CEREBRAL OXIMETRY MONITORS 111
- 4.5.5 INTRACRANIAL PRESSURE MONITORS 112
- 4.6 PRENATAL, FETAL AND NEONATAL MONITORS 114
- 4.6.1 ULTRASOUND AND ULTRASONOGRAPHY 116
- 4.6.2 FETAL DOPPLER 118
- 4.6.3 FETAL MAGNETIC RESONANCE IMAGING 120
- 4.6.4 FETAL MONITORS 121
- 4.6.5 INFANT WARMERS AND INCUBATORS 123
- 4.6.6 PHOTOTHERAPY EQUIPMENT 125
- 4.6.7 NEONATAL MONITORING DEVICE 126
- 4.6.8 RESPIRATORY ASSISTANCE AND MONITORING DEVICES 128
- 4.7 RESPIRATORY MONITORING DEVICES 129
- 4.7.1 CAPNOGRAPHS 132
- 4.7.2 SPIROMETER 134
- 4.7.3 ANESTHESIA MONITORS 135
- 4.7.4 SLEEP APNEA MONITORS 136
- 4.7.5 PULSE OXIMETERS 138
- 4.8 REMOTE PATIENT MONITORING DEVICES 140
- 4.8.1 HEMODYNAMIC MONITORING DEVICES 143
- 4.8.2 NEUROMONITORING DEVICES 144
- 4.8.3 CARDIAC MONITORING DEVICES 145
- 4.8.4 MULTI-PARAMETER MONITORING DEVICES 146
- 4.8.5 OTHERS 147
- 4.9 MICRO-ELECTROMECHANICAL SYSTEMS 148
- 4.9.1 ACCELEROMETERS 151
- 4.9.2 GYROSCOPES 153
- 4.9.3 PRESSURE SENSORS 154
- 4.9.4 CHEMICAL AND GAS SENSORS 155
- 4.9.5 THERMAL IR SENSORS 156
- 4.9.6 OPTICAL MEMS 157
- 4.9.7 RF MEMS 158
- 4.9.8 MICROFLUIDIC CHIPS 160
- 4.9.9 SILICON MICROPHONES 161
- 4.9.10 OTHERS 163
- 4.10 TEMPERATURE MONITORING DEVICES 164
- 4.10.1 MERCURY-FILLED THERMOMETERS 166
- 4.10.2 DIGITAL THERMOMETERS 167
- 4.10.3 INFRARED THERMOMETERS 169
- 4.10.4 THERMOMETER STRIPS 170
- 4.11 WEIGHT MONITORING DEVICES 171
5 GLOBAL PATIENT MONITORING SYSTEM MARKET, BY END-USERS 173
- 5.1 INTRODUCTION 173
- 5.2 MEDICAL CENTRE AND MEDICAL SPECIALIST 175
- 5.3 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER 176
- 5.4 LABORATORIES AND DIAGNOSTIC CENTERS 177
- 5.5 HOME-BASED USERS 178
6 REGIONAL MARKET ANALYSIS 181
- 6.1 INTRODUCTION 181
- 6.2 NORTH AMERICA 182
- 6.2.1 U.S. 194
- 6.3 EUROPE 195
- 6.4 ASIA-PACIFIC 208
- 6.5 REST OF THE WORLD 220
7 COMPANY DEVELOPMENTS 233
- 7.1 INTRODUCTION 233
- 7.1.1 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES AS A MAJOR GROWTH STRATEGY OF PATIENT MONITORING PLAYERS 234
- 7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 234
- 7.3 NEW PRODUCT LAUNCH 237
- 7.4 EXPANSION 244
- 7.5 MERGERS AND ACQUISITIONS 245
- 7.6 APPROVALS 248
8 MAJOR COMPANY PROFILES 254
- 8.1 ABBOTT LABORATORIES 254
- 8.1.1 OVERVIEW 254
- 8.1.2 FINANCIALS 255
- 8.1.3 PRODUCT PORTFOLIO 258
- 8.1.4 KEY DEVELOPMENTS 259
- 8.1.5 BUSINESS STRATEGY 260
- 8.1.6 SWOT ANALYSIS 261
- 8.2 BOSTON SCIENTIFIC CORPOARTION 262
- 8.2.1 OVERVIEW 262
- 8.2.2 FINANCIALS 263
- 8.2.3 PRODUCT PORTFOLIO 265
- 8.2.4 KEY DEVELOPMENTS 266
- 8.2.5 BUSINESS STRATEGY 266
- 8.2.6 SWOT ANALYSIS 267
- 8.3 COVIDIEN PLC 268
- 8.3.1 OVERVIEW 268
- 8.3.2 FINANCIALS 268
- 8.3.3 PRODUCT PORTFOLIO 270
- 8.3.4 KEY DEVELOPMENTS 273
- 8.3.5 BUSINESS STRATEGY 274
- 8.3.6 SWOT ANALYSIS 275
- 8.4 GE HEALTHCARE 276
- 8.4.1 OVERVIEW 276
- 8.4.2 FINANCIALS 276
- 8.4.3 PRODUCT PORTFOLIO 278
- 8.4.4 KEY DEVELOPMENTS 279
- 8.4.5 BUSINESS STRATEGY 280
- 8.4.6 SWOT ANALYSIS 281
- 8.5 JOHNSON & JOHNSON 282
- 8.5.1 OVERVIEW 282
- 8.5.2 FINANCIALS 282
- 8.5.3 PRODUCT PORTFOLIO 285
- 8.5.4 KEY DEVELOPMENTS 286
- 8.5.5 BUSINESS STRATEGY 287
- 8.5.6 SWOT ANALYSIS 288
- 8.6 MEDTRONIC INC. 289
- 8.6.1 OVERVIEW 289
- 8.6.2 FINANCIALS 290
- 8.6.3 PRODUCT PORTFOLIO 291
- 8.6.4 KEY DEVELOPMENTS 293
- 8.6.5 BUSINESS STRATEGY 295
- 8.6.6 SWOT ANALYSIS 296
- 8.7 OMRON HEALTHCARE, INC. 297
- 8.7.1 OVERVIEW 297
- 8.7.2 FINANCIALS 298
- 8.7.3 PRODUCT PORTFOLIO 300
- 8.7.4 KEY DEVELOPMENTS 303
- 8.7.5 BUSINESS STRATEGY 304
- 8.7.6 SWOT ANALYSIS 305
- 8.8 PHILIPS HEALTHCARE 306
- 8.8.1 OVERVIEW 306
- 8.8.2 FINANCIALS 306
- 8.8.3 PRODUCT PORTFOLIO 309
- 8.8.4 KEY DEVELOPMENTS 311
- 8.8.5 BUSINESS STRATEGY 312
- 8.8.6 SWOT ANALYSIS 313
- 8.9 ROCHE LTD. 314
- 8.9.1 OVERVIEW 314
- 8.9.2 FINANCIALS 314
- 8.9.3 PRODUCT PORTFOLIO 317
- 8.9.4 KEY DEVELOPMENTS 319
- 8.9.5 BUSINESS STRATEGY 320
- 8.9.6 SWOT ANALYSIS 321
- 8.10 ST. JUDE MEDICAL, INC. 322
- 8.10.1 OVERVIEW 322
- 8.10.2 FINANCIALS 323
- 8.10.3 PRODUCT PORTFOLIO 324
- 8.10.4 KEY DEVELOPMENTS 330
- 8.10.5 BUSINESS STRATEGY 333
- 8.10.6 SWOT ANALYSIS 334
LIST OF TABLES
TABLE 1 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 23
TABLE 2 PATIENT MONITORING MARKET REVENUE, BY DEVICES (2012-2020) ($MN) 73
TABLE 3 CARDIAC MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN) 76
TABLE 4 CARDIAC MONITORING DEVICE MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 77
TABLE 5 ELECTROCARDIOGRAPH MARKET REVENUE, BY REGION, (2012-2020) ($MN) 79
TABLE 6 EVENT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN) 81
TABLE 7 CARDIAC OUTPUT MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN) 82
TABLE 8 HOLTER MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN) 84
TABLE 9 IMPLANTABLE LOOP RECORDER MARKET REVENUE, BY REGION, (2012-2020) ($MN) 85
TABLE 10 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 87
TABLE 11 HEMODYNAMIC MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN) 88
TABLE 12 MERCURY-FREE BLOOD PRESSURE MONITORS 89
TABLE 13 BLOOD PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 91
TABLE 14 BLOOD GLUCOSE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 93
TABLE 15 BLOOD GAS & ELECTROLYTE ANALYZER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 95
TABLE 16 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 96
TABLE 17 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN) 97
TABLE 18 LOW ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 98
TABLE 19 MID ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 99
TABLE 20 HIGH ACUITY MULTI-PARAMETER MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 101
TABLE 21 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 102
TABLE 22 NEUROLOGICAL MONITORS GLOBAL MARKET REVENUE, BY TYPE (2012-2020) ($MN) 103
TABLE 23 ELECTROENCEPHALOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 106
TABLE 24 TRANSCRANIAL DOPPLER GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 108
TABLE 25 MAGNETOENCEPHAOLOGRAPH GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 109
TABLE 26 CEREBRAL OXIMETRY MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 111
TABLE 27 INTRACRANIAL PRESSURE MONITOR GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 113
TABLE 28 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN) 114
TABLE 29 PRENATAL, FETAL & NEONATAL MONITORING DEVICE MARKET REVENUE, BY TYPE (2012-2020) ($MN) 115
TABLE 30 ULTRASOUND & ULTRASONOGRAPHY MARKET REVENUE, BY REGION, (2012-2020) ($MN) 117
TABLE 31 FETAL DOPPLER MARKET REVENUE, BY REGION, (2012-2020) ($MN) 118
TABLE 32 FETAL MAGNETIC RESONANCE IMAGING MARKET REVENUE, BY REGION, (2012-2020) ($MN) 120
TABLE 33 FETAL MONITOR MARKET REVENUE, BY REGION, (2012-2020) ($MN) 122
TABLE 34 INFANT WARMER & INCUBATOR MARKET REVENUE, BY REGION, (2012-2020) ($MN) 123
TABLE 35 PHOTOTHERAPY EQUIPMENT MARKET REVENUE, BY REGION, (2012-2020) ($MN) 125
TABLE 36 NEONATAL MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN) 126
TABLE 37 RESPIRATORY ASSISTANCE & MONITORING DEVICE MARKET REVENUE, BY REGION, (2012-2020) ($MN) 128
TABLE 38 RESPIRATORY PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 129
TABLE 39 RESPIRATORY PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 130
TABLE 40 CAPNOGRAPHS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 132
TABLE 41 SPIROMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 134
TABLE 42 ANESTHESIA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 135
TABLE 43 SLEEP APNEA PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 137
TABLE 44 PULSE OXIMETERS PATIENT MONITORING DEVICES MARKET REVENUE, BY REGION, (2012-2020) ($MN) 138
TABLE 45 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 140
TABLE 46 REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 141
TABLE 47 HEMODYNAMIC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 142
TABLE 48 NEURO REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 143
TABLE 49 CARDIAC REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 144
TABLE 50 MULTI-PARAMETER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 146
TABLE 51 OTHER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 147
TABLE 52 MICRO-ELECTROMECHANICAL SYSTEMS (MEMS) PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 149
TABLE 53 MEMS PATIENT MONITORING GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 150
TABLE 54 ACCELEROMETER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 151
TABLE 55 GYROSCOPE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 152
TABLE 56 PRESSURE SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 154
TABLE 57 CHEMICAL AND GAS SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 155
TABLE 58 THERMAL IR SENSOR MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 156
TABLE 59 OPTICAL MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 157
TABLE 60 RF MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 158
TABLE 61 MICROFLUIDIC CHIP MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 160
TABLE 62 SILICON MICROPHONE MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 161
TABLE 63 OTHER MEMS GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 162
TABLE 64 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 164
TABLE 65 TEMPERATURE PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 165
TABLE 66 MERCURY-FILLED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 166
TABLE 67 DIGITAL THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 167
TABLE 68 INFRARED THERMOMETER PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 169
TABLE 69 TEMPERATURE STRIP PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 170
TABLE 70 WEIGHT PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 171
TABLE 71 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2012-2020) ($MN) 172
TABLE 72 MEDICAL CENTRE AND MEDICAL SPECIALIST GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 174
TABLE 73 PRIMARY HEALTHCARE AND COMMUNITY HEALTHCARE CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 176
TABLE 74 LABORATORIES AND DIAGNOSTIC CENTER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 177
TABLE 75 HOME-BASED USER GLOBAL MARKET REVENUE, BY REGION, (2012-2020) ($MN) 179
TABLE 76 PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION (2012-2020) ($MN) 180
TABLE 77 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN) 183
TABLE 78 NORTH AMERICAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 185
TABLE 79 NORTH AMERICAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 186
TABLE 80 NORTH AMERICAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 187
TABLE 81 NORTH AMERICAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 187
TABLE 82 NORTH AMERICAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 188
TABLE 83 NORTH AMERICAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 189
TABLE 84 NORTH AMERICAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 190
TABLE 85 NORTH AMERICAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 191
TABLE 86 NORTH AMERICAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 192
TABLE 87 NORTH AMERICAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN) 193
TABLE 88 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN) 196
TABLE 89 EUROPEAN CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 198
TABLE 90 EUROPEAN PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 199
TABLE 91 EUROPEAN HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 200
TABLE 92 EUROPEAN MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 200
TABLE 93 EUROPEAN NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 201
TABLE 94 EUROPEAN RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 202
TABLE 95 EUROPEAN REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 203
TABLE 96 EUROPEAN MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 204
TABLE 97 EUROPEAN TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 205
TABLE 98 EUROPEAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN) 206
TABLE 99 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN) 209
TABLE 100 ASIA-PACIFIC CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 211
TABLE 101 ASIA-PACIFIC PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 212
TABLE 102 ASIA-PACIFIC HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 213
TABLE 103 ASIA-PACIFIC MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 213
TABLE 104 ASIA-PACIFIC NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 214
TABLE 105 ASIA-PACIFIC RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 215
TABLE 106 ASIA-PACIFIC REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 216
TABLE 107 ASIA-PACIFIC MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 217
TABLE 108 ASIA-PACIFIC TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 218
TABLE 109 ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN) 219
TABLE 110 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES, (2012-2020) ($MN) 221
TABLE 111 ROW CARDIAC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 223
TABLE 112 ROW PRENATAL, FETAL AND NEONATAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 224
TABLE 113 ROW HEMODYNAMIC MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 225
TABLE 114 ROW MULTI-PARAMETER MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 225
TABLE 115 ROW NEUROLOGICAL MONITOR DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 226
TABLE 116 ROW RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 227
TABLE 117 ROW REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 228
TABLE 118 ROW MICRO-ELECTROMECHANICAL SYSTEM (MEMS) DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 229
TABLE 119 ROW TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY TYPE, (2012-2020) ($MN) 230
TABLE 120 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2012-2020) ($MN) 231
TABLE 121 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2012-2014) 234
TABLE 122 NEW PRODUCT LAUNCHES (2012-2014) 236
TABLE 123 EXPANSION (2012-2014) 243
TABLE 124 MERGERS AND ACQUISITIONS (2014) 245
TABLE 125 APPROVALS (2013 - 2014) 247
TABLE 126 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN) 254
TABLE 127 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 255
TABLE 128 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 256
TABLE 129 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN) 262
TABLE 130 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN) 263
TABLE 131 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGION (2011-2013) ($MN) 264
TABLE 132 COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($MN) 267
TABLE 133 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, (2011-13) ($MN) 268
TABLE 134 COVIDIEN PLC: TOTAL REVENUE, BY REGION (2011-2013) ($MN) 269
TABLE 135 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES (2011 – 2013) ($BN) 275
TABLE 136 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN) 276
TABLE 137 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2011-2013) ($BN) 277
TABLE 138 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES 2011-2013 ($ BN) 281
TABLE 139 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 282
TABLE 140 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY SEGMENTS(2011-2013) ($BN) 283
TABLE 141 JOHNSON & JOHNSON: GEOGRAPHICAL REVENUE, BY REGION (2011-2013) ($BN) 284
TABLE 142 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($MN) 289
TABLE 143 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($MN) 289
TABLE 144 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($MN) 290
TABLE 145 OMRON: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN) 297
TABLE 146 OMRON.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 298
TABLE 147 OMRON: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 299
TABLE 148 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2011-2013) ($BN) 305
TABLE 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2011-2013) ($BN) 306
TABLE 150 PHILIPS N.V.: HEALTHCARE BUSINESS REVENUE (2011-2013) ($BN) 307
TABLE 151 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 308
TABLE 152 ROCHE LTD.: TOTAL REVENUE AND R&D EXPENSES, (2011-2013) ($BN) 313
TABLE 153 ROCHE LTD.: TOTAL REVENUE, BY SEGMENTS, (2011-2013) ($BN) 314
TABLE 154 ROCHE LTD.: DIAGNOSTICS REVENUE, BY SEGMENTS, (2011-2013) ($BN) 315
TABLE 155 ROCHE LTD.: TOTAL REVENUE, BY GEOGRAPHY (2011-2013) ($BN) 316
TABLE 156 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES (2011-13) ($BN) 322
TABLE 157 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENT (2011-13) ($BN) 322
TABLE 158 ST. JUDES MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY (2011-13) ($BN) 323
LIST OF FIGURES
FIGURE 1 GLOBAL PATIENT MONITORING MARKET SHARE, BY GEOGRAPHY (2012-2020) 24
FIGURE 2 RESEARCH METHODOLOGY: PATIENT MONITORING MARKET 31
FIGURE 3 PATIENT MONITORING MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 32
FIGURE 4 PATIENT MONITORING MARKET: FORECASTING MODEL 33
FIGURE 5 PATIENT MONITORING MARKET: MARKET CRACKDOWN & DATA TRIANGULATION 34
FIGURE 6 GLOBAL PATIENT MONITORING DEVICE MARKET: MARKET SEGMENTATION 38
FIGURE 7 MARKET DYNAMICS 39
FIGURE 8 PATIENT MONITORING DEVICES: PORTER’S ANALYSIS 46
FIGURE 9 GLOBAL PATIENT MONITORING DEVICES MARKET SHARE ANALYSIS, BASED ON MARKET REVENUE, 2013 51
FIGURE 10 GLOBAL PATIENT MONITORING DEVICE, MARKET SHARE VS CAGR (2012 – 2020) 74
FIGURE 11 CARDIAC MONITORING MARKET SHARE (2013 VS 2020) 77
FIGURE 12 NEUROLOGICAL MARKET SHARE: 2013 VS 2020 104
FIGURE 13 RESPIRATORY MONITORS MARKET SHARE 2013 VS 2020 131
FIGURE 14 REMOTE PATIENT MONITORING MARKET SHARE 2013 VS 2020 141
FIGURE 15 PATIENT MONITORING MARKET REVENUE: BY ENDUSERS 173
FIGURE 16 GLOBAL PATIENT MONITORING SCENARIO, BY REGION, 2012 – 2020 ($MN) 181
FIGURE 17 NORTH AMERICA PATIENT MONITORING MARKET REVENUE BY DEVICES (2013) 184
FIGURE 18 EUROPEAN PM’S MARKET REVENUE BY DEVICES 197
FIGURE 19 ASIA PACIFIC PATIENT MONITORING MARKET REVENUE BY DEVICES 210
FIGURE 20 ROW PATIENT MONITORING MARKET REVENUE BY DEVICES 222
FIGURE 21 KEY GROWTH STRATEGIES, (2012 – 2014) 232
FIGURE 22 SWOT: ABBOTT LABORATORIES INC 260
FIGURE 23 SWOT ANALYSIS: BOSTON SCIENTIFIC 266
FIGURE 24 SWOT: COVIDIEN PLC 274
FIGURE 25 SWOT: GE HEALTHCARE 280
FIGURE 26 SWOT: JOHNSON & JOHNSON 287
FIGURE 27 SWOT: MEDTRONIC 295
FIGURE 28 SWOT: OMRON HEALTHCARE INC 304
FIGURE 29 SWOT: PHILIPS HEALTHCARE 312
FIGURE 30 SWOT ANALYSIS: ROCHE DIAGNOSTICS 320
FIGURE 31 SWOT: ST JUDE MEDICAL 333
Patient monitoring market is mounting as a result of advancement in upcoming technologies that is providing an excellent opportunity for cultivating improvised care for patients across every corner of the globe. Patient monitoring system involves continuous/semi-continuous measurement of patient’s physiological parameters such as heart rate, respiratory rate, blood pressure, core temperatures and pulse oximetry etc., which accelerates patient’s quality care by making superior clinical-decision. Patient monitoring plays a fundamental role in emergency and operating rooms, intensive and critical care units by reducing onset of complications and risks in patient. It is proven to be very useful in respiratory therapy, recovery rooms, out-patient care, transport, radiology, cath labs, gastroenterology departments, ambulatory, home, and sleep screening applications.
Patient monitoring devices market is mainly divided into following segments such as by-devices, by-end-users. Patient Monitoring market by-devices are classified into cardiac monitors, fetal, prenatal and neonatal monitors, hemodynamic monitors, multi-parameter monitors, neurological monitors, respiratory monitors, remote patient monitors, micro electromechanical systems-based monitors, temperature and weight monitors. PM market by-end-users are divided into medical centers and medical specialist, primary healthcare and community healthcare centers, laboratories and diagnostic centers and home-based users.
Patient monitoring devices are requisite part of medical team for every procedure i.e. operating in a clinic or multi specialty hospitals. The reduction in size of the monitors over the years through contemporary technologies and rising adoption of telemetry and remote monitoring has increased the growth of the patient monitoring devices. Cardiac monitoring segment commanded the largest share in global patient monitoring market for 2013 and is expected to maintain its strong share by 2019. Multi-parameter monitoring is the second largest share holder in the market. Moreover, respiratory monitoring and neurological monitors is the fastest growing segments due to rising incidence of respiratory and neuro-degenerative diseases and demand for portable devices.
The global patient monitoring devices market is expected to reach approximately $24,353 million by 2020 growing at CAGR of around 5.2%. Geographically, North America commands the largest share and is expected to record a healthy market share by $9,681 million by 2020. APAC is going to be one of the prominent regions for this market in coming years driven by healthcare awareness, high purchasing power and rising population.